Executive Gov
KPMG has developed a technology architecture to match patients in clinical trials for convalescent plasma therapy to recovered patients willing to donate their antibodies, to advance the response and recovery of COVID-19 patients, the company reported on Thursday.
Read More »KPMG Launches New Tech Architecture to Drive COVID-19 Recovery; Cliff Justice, Bharat Rao Quoted
